๐Ÿงฌ GLP-1 vs GLP2TZ vs GLP3RT: What's the Difference?

Category: GLP Research
Reading Time: 8 minutes
Last Reviewed: August 2026


Introduction

As peptide research has expanded, several compounds have become widely studied for how they interact with the body's metabolic signaling systems. Three of the most recognized are GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, and triple receptor agonists.

Although these compounds share similarities, they differ in the number of biological receptor systems they are designed to activate. Understanding these differences can help explain why researchers continue investigating each class separately.

This article provides an educational overview of GLP1SM (Semaglutide), GLP2TZ (Tirzepatide), and GLP3RT (Retatrutide).


Quick Comparison

 

Feature                                           GLP1SM (Semaglutide)                            GLP2TZ (Tirzepatide)                                  GLP3RT (Retatrutide)

Receptor Activity                                 GLP-1                                                        GLP-1 + GIP                                            GLP-1 + GIP + Glucagon

Number of Receptors                              1                                                            2                                                                     3

Molecule Type                                    Synthetic peptide                                  Synthetic peptide                                      Synthetic peptide

Research Focus                                 GLP-1 signaling                                Dual hormone signaling                               Triple hormone signaling

Current Research Status                                     Extensive                                   Extensive                                                             Emerging

 


Understanding the Three Receptor Systems

GLP-1 Receptor

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone involved in regulating glucose metabolism, digestion, and appetite signaling.

Researchers study GLP-1 receptor activation to better understand metabolic regulation and endocrine communication.


GIP Receptor

Glucose-dependent insulinotropic polypeptide (GIP) is another naturally occurring hormone involved in metabolic signaling.

Scientists continue investigating how GIP interacts with GLP-1 pathways and how the two systems work together.


Glucagon Receptor

Glucagon is a hormone involved in maintaining glucose availability and regulating energy metabolism.

Adding glucagon receptor activity introduces another area of investigation into how multiple hormonal pathways interact.


GLP1SM (Semaglutide)

GLP1SM is designed to activate only the GLP-1 receptor.

Researchers study it primarily to understand:

  • GLP-1 biology
  • Hormonal signaling
  • Metabolic regulation
  • Endocrine physiology
  • Cellular communication

Because it targets a single receptor pathway, GLP1SM is often used as a reference point when comparing newer multi-receptor compounds.

GLP-1 is a hormone naturally produced by specialized cells in the small intestine after eating. It is part of the body's incretin system and plays an important role in coordinating metabolic signaling.

Researchers study GLP-1 because it is involved in:

  • Blood glucose regulation
  • Communication between the digestive system and pancreas
  • Appetite-related signaling
  • Gastric emptying
  • Insulin and glucagon signaling
  • Energy balance

GLP-1 receptor agonists, such as Semaglutide (GLP1SM), are designed to activate this receptor pathway


GLP2TZ (Tirzepatide)

GLP2TZ activates two receptor systems:

  • GLP-1
  • GIP

Scientists continue studying how activation of these two pathways may differ from compounds that target only GLP-1 receptors.

Research involving GLP2TZ focuses on understanding interactions between multiple metabolic signaling systems.

GLP-2 is a hormone naturally produced by specialized L cells in the small intestine after eating. Like GLP-1, it is derived from the proglucagon molecule and released as part of the body's response to food intake. However, GLP-2 primarily functions within the gastrointestinal system rather than metabolic regulation.

Researchers study GLP-2 because it is involved in:

  • Intestinal growth and maintenance
  • Nutrient absorption
  • Gut barrier integrity
  • Intestinal blood flow
  • Gastrointestinal repair and adaptation
  • Digestive system signaling
  • Communication between intestinal cells and surrounding tissues

GLP-2 receptor agonists, such as Teduglutide, are designed to activate this receptor pathway and have been studied for their effects on intestinal physiology and gastrointestinal function.


GLP3RT (Retatrutide)

GLP3RT represents the newest generation of compounds currently under investigation.

Unlike earlier compounds, it interacts with three receptor systems:

  • GLP-1
  • GIP
  • Glucagon

Researchers continue studying how simultaneous activation of these three pathways influences endocrine signaling and metabolic regulation.

Unlike GLP-1 and GLP-2, GLP-3 is not a naturally occurring hormone found in the human body. Instead, the term "GLP-3" is commonly used to describe a new generation of triple receptor agonist research compounds, such as Retatrutide (GLP3RT).

Rather than activating a single hormone pathway, triple agonists are designed to interact with three naturally occurring receptor systems:

  • GLP-1 receptor
  • GIP receptor
  • Glucagon receptor

Researchers study triple receptor agonists because they combine multiple metabolic signaling pathways into a single molecule.

Current areas of research include:

  • Multi-receptor metabolic signaling
  • Endocrine communication
  • Energy balance
  • Glucose regulation
  • Lipid metabolism
  • Hormonal pathway interactions
  • Whole-body metabolic physiology

Triple receptor agonists, such as Retatrutide (GLP3RT), are designed to activate all three receptor pathways simultaneously, making them an active area of metabolic and endocrine research.


Why Are Scientists Interested in Multi-Receptor Peptides?

One area of modern peptide research involves understanding whether activating multiple receptor systems produces different biological responses compared with activating a single receptor.

Current investigations explore:

  • Hormonal communication
  • Cellular signaling
  • Endocrine regulation
  • Energy metabolism
  • Receptor interactions

Research in this area continues to evolve, and scientists are still learning how these signaling pathways work together.


Side-by-Side Summary

 

Compound                                                                            Primary Scientific Interest

GLP1SM                                                                                   GLP-1 receptor biology

GLP2TZ                                                                                    Dual receptor signaling

GLP3RT                                                                                   Triple receptor signaling

 


Frequently Asked Questions

Are these the same compound?

No. Although they belong to a related class of research peptides, each compound has a different molecular structure and interacts with a different combination of biological receptors.

Why is GLP3RT called a "triple agonist"?

Because researchers study it for its interaction with three receptor systems:

  • GLP-1
  • GIP
  • Glucagon

Does more receptors automatically mean better?

Not necessarily. The number of receptor systems involved does not determine superiority. Each compound is investigated for different scientific questions, and researchers continue evaluating how these signaling pathways function individually and together.

Why are these compounds compared so often?

Because they represent successive generations of peptide research, with each newer compound expanding the number of receptor pathways under investigation.


Key Takeaways

โœ” GLP1SM targets one receptor (GLP-1).

โœ” GLP2TZ targets two receptors (GLP-1 and GIP).

โœ” GLP3RT targets three receptors (GLP-1, GIP, and glucagon).

โœ” All three remain important areas of scientific research, but they differ in structure and receptor activity.


Continue Learning


Educational Notice

This article is intended solely for educational and informational purposes. It summarizes scientific terminology, biological mechanisms, and areas of published research. It does not establish the safety, effectiveness, identity, purity, or approved use of any particular research material. Nothing in this article should be interpreted as medical advice, treatment guidance, dosing information, or a recommendation for human or animal use. ResearchPeps products are offered strictly for laboratory research purposes.